Case and Research Letter
Need to Screen for Chagas Disease and Strongyloides Infestation in Non-endemic Countries Prior to Treatment With Biologics
Necesidad de cribado de enfermedad de Chagas y de infestación por Strongyloides previo a inicio de terapia biológica en países no endémicos
Leído
5450
Vecesse ha leído el artículo
1715
Total PDF
3735
Total HTML
Compartir estadísticas
array:24 [ "pii" => "S1578219017300471" "issn" => "15782190" "doi" => "10.1016/j.adengl.2017.02.018" "estado" => "S300" "fechaPublicacion" => "2017-05-01" "aid" => "1552" "copyright" => "Elsevier España, S.L.U. and AEDV" "copyrightAnyo" => "2016" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Actas Dermosifiliogr. 2017;108:373-5" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 753 "formatos" => array:3 [ "EPUB" => 49 "HTML" => 550 "PDF" => 154 ] ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S0001731016303684" "issn" => "00017310" "doi" => "10.1016/j.ad.2016.10.013" "estado" => "S300" "fechaPublicacion" => "2017-05-01" "aid" => "1552" "copyright" => "AEDV" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Actas Dermosifiliogr. 2017;108:373-5" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 257 "formatos" => array:3 [ "EPUB" => 4 "HTML" => 217 "PDF" => 36 ] ] "es" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">CARTA CIENTÍFICO-CLÍNICA</span>" "titulo" => "Necesidad de cribado de enfermedad de Chagas y de infestación por <span class="elsevierStyleItalic">Strongyloides</span> previo a inicio de terapia biológica en países no endémicos" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "373" "paginaFinal" => "375" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Need to screen for Chagas disease and <span class="elsevierStyleItalic">Strongyloides</span> infestation in non-endemic countries prior to treatment with biologics" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "J. González-Ramos, M.L. Alonso-Pacheco, M. Mora-Rillo, P. Herranz-Pinto" "autores" => array:4 [ 0 => array:2 [ "nombre" => "J." "apellidos" => "González-Ramos" ] 1 => array:2 [ "nombre" => "M.L." "apellidos" => "Alonso-Pacheco" ] 2 => array:2 [ "nombre" => "M." "apellidos" => "Mora-Rillo" ] 3 => array:2 [ "nombre" => "P." "apellidos" => "Herranz-Pinto" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S1578219017300471" "doi" => "10.1016/j.adengl.2017.02.018" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219017300471?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731016303684?idApp=UINPBA000044" "url" => "/00017310/0000010800000004/v2_201705020105/S0001731016303684/v2_201705020105/es/main.assets" ] ] "itemSiguiente" => array:19 [ "pii" => "S1578219017300653" "issn" => "15782190" "doi" => "10.1016/j.adengl.2016.10.006" "estado" => "S300" "fechaPublicacion" => "2017-05-01" "aid" => "1550" "copyright" => "Elsevier España, S.L.U. and AEDV" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Actas Dermosifiliogr. 2017;108:376-7" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 676 "formatos" => array:3 [ "EPUB" => 54 "HTML" => 505 "PDF" => 117 ] ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Case and Research Letter</span>" "titulo" => "Basal Cell Carcinoma in Young Adults" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "376" "paginaFinal" => "377" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Carcinoma basocelular en pacientes jóvenes" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "J. Garcias-Ladaria, F.J. Morales-Morato, M. Cuadrado Rosón, V. Rocamora" "autores" => array:4 [ 0 => array:2 [ "nombre" => "J." "apellidos" => "Garcias-Ladaria" ] 1 => array:2 [ "nombre" => "F.J." "apellidos" => "Morales-Morato" ] 2 => array:2 [ "nombre" => "M." "apellidos" => "Cuadrado Rosón" ] 3 => array:2 [ "nombre" => "V." "apellidos" => "Rocamora" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0001731016303660" "doi" => "10.1016/j.ad.2016.10.012" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731016303660?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219017300653?idApp=UINPBA000044" "url" => "/15782190/0000010800000004/v1_201704280927/S1578219017300653/v1_201704280927/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S1578219017300677" "issn" => "15782190" "doi" => "10.1016/j.adengl.2017.03.013" "estado" => "S300" "fechaPublicacion" => "2017-05-01" "aid" => "1553" "copyright" => "Elsevier España, S.L.U. and AEDV" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Actas Dermosifiliogr. 2017;108:371-2" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 547 "formatos" => array:3 [ "EPUB" => 66 "HTML" => 353 "PDF" => 128 ] ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Case and Research Letter</span>" "titulo" => "Pilot Study to Evaluate Postsurgical Dehiscence After Continuous Suture by Tissue Planes" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "371" "paginaFinal" => "372" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Estudio piloto de valoración de dehiscencias posquirúrgicas tras sutura continua por planos" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "J. Tercedor-Sánchez, A. Martinez-Lopez, I. Pérez-López, R. Ruiz-Villaverde" "autores" => array:4 [ 0 => array:2 [ "nombre" => "J." "apellidos" => "Tercedor-Sánchez" ] 1 => array:2 [ "nombre" => "A." "apellidos" => "Martinez-Lopez" ] 2 => array:2 [ "nombre" => "I." "apellidos" => "Pérez-López" ] 3 => array:2 [ "nombre" => "R." "apellidos" => "Ruiz-Villaverde" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0001731016303696" "doi" => "10.1016/j.ad.2016.10.014" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731016303696?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219017300677?idApp=UINPBA000044" "url" => "/15782190/0000010800000004/v1_201704280927/S1578219017300677/v1_201704280927/en/main.assets" ] "en" => array:16 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Case and Research Letter</span>" "titulo" => "Need to Screen for Chagas Disease and <span class="elsevierStyleItalic">Strongyloides</span> Infestation in Non-endemic Countries Prior to Treatment With Biologics" "tieneTextoCompleto" => true "saludo" => "To the Editor:" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "373" "paginaFinal" => "375" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "J. González-Ramos, M.L. Alonso-Pacheco, M. Mora-Rillo, P. Herranz-Pinto" "autores" => array:4 [ 0 => array:4 [ "nombre" => "J." "apellidos" => "González-Ramos" "email" => array:1 [ 0 => "gnzalezramosjessica@gmail.com" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "M.L." "apellidos" => "Alonso-Pacheco" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 2 => array:3 [ "nombre" => "M." "apellidos" => "Mora-Rillo" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] 3 => array:3 [ "nombre" => "P." "apellidos" => "Herranz-Pinto" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] ] "afiliaciones" => array:2 [ 0 => array:3 [ "entidad" => "Servicio de Dermatología, Hospital Universitario La Paz, Madrid, Spain" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Unidad de Enfermedades Infecciosas, Servicio de Medicina Interna, Hospital Universitario La Paz, Madrid, Spain" "etiqueta" => "b" "identificador" => "aff0010" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Necesidad de cribado de enfermedad de Chagas y de infestación por <span class="elsevierStyleItalic">Strongyloides</span> previo a inicio de terapia biológica en países no endémicos" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">We describe the case of a 54-year-old Bolivian woman who had lived in Spain for 14 years. The patient a history of hypertension, asthma, and urticaria with chronic angioedema that had first appeared 6 years earlier; she had been assessed and treated for the urticaria and angioedema at another care facility. In March 2012, the patient started receiving subcutaneous etanercept (50<span class="elsevierStyleHsp" style=""></span>mg/wk) for treatment of psoriasis and psoriatic arthritis that had not responded to treatment with methotrexate and oral corticosteroids. After 3 months, complete response was achieved in the skin and partial response was achieved in the joints. Because of persistent peripheral blood eosinophilia (> 1000/μL), the patient underwent screening for associated diseases. The serologic findings (enzyme-linked immunosorbent assay was positive for IgG) indicated <span class="elsevierStyleItalic">Strongyloides stercoralis</span> infestation, which was treated with oral ivermectin (200<span class="elsevierStyleHsp" style=""></span>μg/kg/d for 2 days) in February 2013. Direct parasitological stool examination and stool cultures performed in triplicate were negative before and after treatment. One year later, during follow-up, the patient was screened for Chagas disease, with positive findings in blood tests (enzyme immunoassay and indirect immunofluorescence) and polymerase chain reaction (PCR). Organ involvement was ruled out by a standardized test and the disease stage was classified as indeterminate. Because of the risk of reactivation, etanercept was withdrawn and treatment was initiated with oral benznidazole (5<span class="elsevierStyleHsp" style=""></span>mg/kg/d for 60 days) and biologic therapy was subsequently resumed. In the past 18 months, no reactivation of the infection has been observed (PCR remains negative and serology is positive with lower titers) despite ongoing treatment with etanercept.</p><p id="par0010" class="elsevierStylePara elsevierViewall">Chagas disease, caused by the <span class="elsevierStyleItalic">Trypanosoma cruzi</span> parasite, affects approximately 10 million people worldwide, especially in South America, where it causes thousands of deaths each year. In recent decades, because of migratory flows, the disease has spread to nonendemic areas such as Spain, where the use of biologic therapy is on the rise. In our area, most patients are diagnosed with Chagas disease of indeterminate stage (positive serology, fluctuating parasitemia, and absence of symptoms) and can remain in that stage indefinitely or progress to the symptomatic chronic stage after 10 to 30 years.<a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">1</span></a> Immunosuppression alters the natural history of the disease, facilitating reactivation and progression to advanced stages. Reactivation is defined as an increase in parasitemia that can be detected by PCR, with the methods of choice being quantitative PCR (a mode not available in our case) or direct examination. The disease can be associated with severe symptoms of organ involvement, such as myocarditis or meningoencephalitis, or it can be asymptomatic. Reactivation has been widely reported in patients with human immunodeficiency virus (HIV) infection, transplant recipients, and patients receiving conventional immunosuppressive therapy. Currently, there is no evidence that corticosteroids at immunosuppressive doses increase the risk of reactivation. In immunosuppressed patients, treatment with benznidazole or nifurtimox is indicated (recommendation grade BII).<a class="elsevierStyleCrossRef" href="#bib0060"><span class="elsevierStyleSup">2</span></a> Criteria of cure are not well defined, although the patient is assumed to be cured if successive PCR tests are negative after treatment. Serologic testing is not useful because it can take years to achieve negative seroconversion.<a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">1</span></a></p><p id="par0015" class="elsevierStylePara elsevierViewall">Anti-TNF agents have been associated with an increased risk of opportunistic infections. In the French RATIO registry of nontuberculous opportunistic infections in patients receiving anti-TNF therapy, 45 cases of such infections were detected over a 3-year period. The risk of infection was not statistically significant with any drug, although it was higher with infliximab and adalimumab than with etanercept.<a class="elsevierStyleCrossRef" href="#bib0065"><span class="elsevierStyleSup">3</span></a> This risk is still being assessed and more data on reactivation rates of parasitic infections are needed. Only 2 cases of reactivation of Chagas disease in patients receiving biologic therapy have been reported; both patients had psoriasis and were receiving treatment with infliximab and adalimumab, respectively (<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>).<a class="elsevierStyleCrossRefs" href="#bib0070"><span class="elsevierStyleSup">4,5</span></a></p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><p id="par0020" class="elsevierStylePara elsevierViewall">Little information is available on the need for serologic screening for Chagas disease before the initiation of biological treatment. Salvador et al. recommend screening patients from endemic areas and performing prior treatment with benznidazole in infected patients. During follow-up, the authors recommend closely monitoring patients with PCR for early detection of reactivation.<a class="elsevierStyleCrossRef" href="#bib0080"><span class="elsevierStyleSup">6</span></a></p><p id="par0025" class="elsevierStylePara elsevierViewall">The prevalence of infection with <span class="elsevierStyleItalic">S stercoralis</span>, a human intestinal nematode, has also increased in recent years in Spain. The infestation is endemic in tropical and subtropical regions, but there are also endemic areas in Spain, especially on the Mediterranean coast. Diagnosis is made by stool culture on agar plate and/or serologic testing. Immunosuppressed patients are at risk of hyperinfestation syndrome, which is associated with high mortality.<a class="elsevierStyleCrossRef" href="#bib0065"><span class="elsevierStyleSup">3</span></a> Four cases have been reported in patients receiving anti-TNF therapy (<a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>).<a class="elsevierStyleCrossRefs" href="#bib0085"><span class="elsevierStyleSup">7–10</span></a> In patients from endemic areas, it appears that screening for <span class="elsevierStyleItalic">S stercoralis</span> before the start of biologic therapy would be advisable and, in the event of infestation, treatment should be initiated with oral ivermectin (200<span class="elsevierStyleHsp" style=""></span>μg/kg/d for 2 consecutive days), which has been shown to be the most effective therapy.<a class="elsevierStyleCrossRef" href="#bib0065"><span class="elsevierStyleSup">3</span></a></p><elsevierMultimedia ident="tbl0010"></elsevierMultimedia><p id="par0030" class="elsevierStylePara elsevierViewall">In conclusion, we consider that pre-screening for Chagas disease and <span class="elsevierStyleItalic">Strongyloides</span> infestation, as is already established for detection of latent tuberculosis infection in international clinical guidelines for biologic therapy, is necessary in patients from endemic areas or who have lived in endemic areas (<a class="elsevierStyleCrossRef" href="#tbl0015">Table 3</a>). The aim of this screening is to decrease the morbidity and mortality that these diseases could bring to our area in the coming years.</p><elsevierMultimedia ident="tbl0015"></elsevierMultimedia><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0005">Conflicts of Interest</span><p id="par0035" class="elsevierStylePara elsevierViewall">The authors declare that they have no conflicts of interest.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:3 [ 0 => array:2 [ "identificador" => "sec0005" "titulo" => "Conflicts of Interest" ] 1 => array:2 [ "identificador" => "xack280253" "titulo" => "Acknowledgments" ] 2 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0015">Please cite this article as: González-Ramos J, Alonso-Pacheco ML, Mora-Rillo M, Herranz-Pinto P. Necesidad de cribado de enfermedad de Chagas y de infestación por <span class="elsevierStyleItalic">Strongyloides</span> previo a inicio de terapia biológica en países no endémicos. Actas Dermosifiliogr. 2017;108:373–375.</p>" ] ] "multimedia" => array:3 [ 0 => array:8 [ "identificador" => "tbl0005" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at1" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:3 [ "leyenda" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Abbreviations: F, female; M, male.</p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Case/Year \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Sex/Age, y \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Country \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Primary Disease \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Biologic Agent \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Concomitant Immunosuppressive Treatments \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Interval<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">a</span></a> \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Treatment \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Management \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">1/2015<a class="elsevierStyleCrossRef" href="#bib0070"><span class="elsevierStyleSup">4</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">M/57 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Argentina \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Psoriatic erythroderma \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Infliximab \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Methylprednisolone 20<span class="elsevierStyleHsp" style=""></span>mg/d \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">1 mo \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Benznidazole \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">None reported \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">2/2015<a class="elsevierStyleCrossRef" href="#bib0075"><span class="elsevierStyleSup">5</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">M/52 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Chile \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Psoriasis \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Adalimumab 40<span class="elsevierStyleHsp" style=""></span>mg twice weekly \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">– \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">1 y \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Benznidazole 5-7<span class="elsevierStyleHsp" style=""></span>mg/kg/d<span class="elsevierStyleHsp" style=""></span>×<span class="elsevierStyleHsp" style=""></span>2 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Adalimumab treatment was resumed. No reactivation in 1 year. \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Present case/2016 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">F/54 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Bolivia \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Psoriasis<span class="elsevierStyleHsp" style=""></span>+<span class="elsevierStyleHsp" style=""></span>psoriatic arthritis \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Etanercept 50<span class="elsevierStyleHsp" style=""></span>mg/wk \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Methotrexate 25<span class="elsevierStyleHsp" style=""></span>mg/wk, prednisone 5<span class="elsevierStyleHsp" style=""></span>mg/d \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">27 mo \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Benznidazole 5<span class="elsevierStyleHsp" style=""></span>mg/kg/d \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Etanercept treatment was resumed. No reactivation in 2 years. \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab1406725.png" ] ] ] "notaPie" => array:1 [ 0 => array:3 [ "identificador" => "tblfn0005" "etiqueta" => "a" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Time elapsed from the start of biologic therapy to the diagnosis of the infection.</p>" ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Reported Cases of Reactivation of Chagas Disease in Patients Receiving Biologic Therapy and Management.</p>" ] ] 1 => array:8 [ "identificador" => "tbl0010" "etiqueta" => "Table 2" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at2" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:3 [ "leyenda" => "<p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">Abbreviations: F, female; M, male.</p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Case/Year \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Sex/Age, y \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Country \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Primary Disease \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Biologic Agent \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Concomitant Immunosuppressive Treatments \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Interval<a class="elsevierStyleCrossRef" href="#tblfn0010"><span class="elsevierStyleSup">a</span></a> \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Treatment \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">1/2005<a class="elsevierStyleCrossRef" href="#bib0085"><span class="elsevierStyleSup">7</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">M/56 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Spent time in Vietnam and Mississippi \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Rheumatoid arthritis \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Etanercept \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Prednisone 5<span class="elsevierStyleHsp" style=""></span>mg/d \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">4 wk \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Intravenous ivermectin 200<span class="elsevierStyleHsp" style=""></span>μg/kg/d <span class="elsevierStyleHsp" style=""></span>×<span class="elsevierStyleHsp" style=""></span>2 d \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">2/2007<a class="elsevierStyleCrossRef" href="#bib0090"><span class="elsevierStyleSup">8</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">M/63 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Philippines \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Rheumatoid arthritis \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Adalimumab \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Methotrexate 15<span class="elsevierStyleHsp" style=""></span>mg/wk and prednisone 5<span class="elsevierStyleHsp" style=""></span>mg/d \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">3 mo \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Ivermectin 200<span class="elsevierStyleHsp" style=""></span>μg/kg/d<span class="elsevierStyleHsp" style=""></span>×<span class="elsevierStyleHsp" style=""></span>2 d \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">3/2008<a class="elsevierStyleCrossRef" href="#bib0095"><span class="elsevierStyleSup">9</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">M/29 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Ecuador \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Rheumatoid arthritis \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Etanercept \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">None \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">24 and 30 mo \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Albendazole 400<span class="elsevierStyleHsp" style=""></span>mg/12<span class="elsevierStyleHsp" style=""></span>h, followed by ivermectin 12<span class="elsevierStyleHsp" style=""></span>mg (single dose) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">4/2013<a class="elsevierStyleCrossRef" href="#bib0100"><span class="elsevierStyleSup">10</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">M/55 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">None reported \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Ankylosing spondylitis \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Infliximab \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Oral corticosteroids \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">10 d \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Albendazole 400<span class="elsevierStyleHsp" style=""></span>mg/d<span class="elsevierStyleHsp" style=""></span>×<span class="elsevierStyleHsp" style=""></span>7 d \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Present case/2016 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">F/54 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Bolivia \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Psoriasis<span class="elsevierStyleHsp" style=""></span>+<span class="elsevierStyleHsp" style=""></span>psoriatic arthritis \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Etanercept \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Methotrexate 25<span class="elsevierStyleHsp" style=""></span>mg/wk, prednisone 5<span class="elsevierStyleHsp" style=""></span>mg/d \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">11 mo \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Oral ivermectin 200<span class="elsevierStyleHsp" style=""></span>μg/kg/d<span class="elsevierStyleHsp" style=""></span>×<span class="elsevierStyleHsp" style=""></span>2 d \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab1406723.png" ] ] ] "notaPie" => array:1 [ 0 => array:3 [ "identificador" => "tblfn0010" "etiqueta" => "a" "nota" => "<p class="elsevierStyleNotepara" id="npar0010">Time elapsed from the start of biologic therapy to the diagnosis of the infection.</p>" ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Reported Cases of <span class="elsevierStyleItalic">Strongyloides stercoralis</span> Infestation in Patients Receiving Biologic Therapy and Treatment.</p>" ] ] 2 => array:8 [ "identificador" => "tbl0015" "etiqueta" => "Table 3" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at3" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:2 [ "leyenda" => "<p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">Abbreviation: PCR, polymerase chain reaction.</p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Infectious Agent \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Diagnostic Methods \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Strongyloides stercoralis</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Direct stool examination, stool culture, serologic testing \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Trypanosoma cruzi</span> (Chagas disease) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">2 different blood tests. PCR (only if serology is positive) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Plasmodium falciparum</span> (if the patient has been in Spain<span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>2 y) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Peripheral blood smear, immunochromatography, PCR \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Entamoeba histolytica</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Serology \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Human T-lymphotrophic virus type 1</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Serology \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Endemic mycoses (<span class="elsevierStyleItalic">Histoplasma, Coccidioides, Paracoccidioides, Blastomyces)</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Serology \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab1406724.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">Screening for Nontuberculous Opportunistic Infections Recommended in Patients From Endemic Areas Before Initiation of Biologic Therapy.</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:10 [ 0 => array:3 [ "identificador" => "bib0055" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Chagas’ disease" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "C. Bern" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJMra1410150" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "2015" "volumen" => "373" "paginaInicial" => "456" "paginaFinal" => "466" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26222561" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0060" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Immunosuppression and Chagas disease: A management challenge" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M.J. Pinazo" 1 => "G. Espinosa" 2 => "C. Cortes-Lletget" 3 => "E. de J. Posada" 4 => "E. Aldasoro" 5 => "I. Oliveira" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1371/journal.pntd.0001965" "Revista" => array:5 [ "tituloSerie" => "PLoS Negl Trop Dis" "fecha" => "2013" "volumen" => "7" "paginaInicial" => "e1965" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23349998" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0065" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Uncommon infections to consider when prescribing biological agents" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "R. Rivera" 1 => "F. Vanaclocha" 2 => "M. Lizasoaín" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Piel (Barc)" "fecha" => "2013" "volumen" => "28" "paginaInicial" => "31" "paginaFinal" => "36" ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0070" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Valledor A, Fernandez V, Stanek V, Barcan L. Primer reporte de reactivación de enfermedad de Chagas asociado a infliximab. Communication presented at XV Congreso Argentino de la Sociedad Argentina de Infectología. Buenos Aires, May 28–30, 2015. Sociedad Argentina de Infectología." ] ] ] 4 => array:3 [ "identificador" => "bib0075" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Use of tumor necrosis factor alpha (TNF-α) antagonists in a patient with psoriasis and Chagas disease" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "C. Navarrete-Dechent" 1 => "D. Majerson" 2 => "M. Torres" 3 => "D. Armijo" 4 => "M. Patel" 5 => "A. Menter" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1590/abd1806-4841.20153538" "Revista" => array:7 [ "tituloSerie" => "An Bras Dermatol" "fecha" => "2015" "volumen" => "90" "numero" => "S 1" "paginaInicial" => "171" "paginaFinal" => "174" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26312707" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0080" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Immunosuppression and Chagas disease; experience from a non-endemic country" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "F. Salvador" 1 => "A. Sánchez-Montalvá" 2 => "L. Valerio" 3 => "N. Serre" 4 => "S. Roure" 5 => "B. Treviño" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.cmi.2015.05.033" "Revista" => array:6 [ "tituloSerie" => "Clin Microbiol Infect" "fecha" => "2015" "volumen" => "21" "paginaInicial" => "854" "paginaFinal" => "860" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26055418" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0085" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Clinical infection with <span class="elsevierStyleItalic">Strongyloides stercoralis</span> following etanercept use for rheumatoid arthritis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "M.D. Boatright" 1 => "B.W. Wang" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/art.20882" "Revista" => array:6 [ "tituloSerie" => "Arthritis Rheum" "fecha" => "2005" "volumen" => "52" "paginaInicial" => "1336" "paginaFinal" => "1337" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15818680" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0090" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "<span class="elsevierStyleItalic">Strongyloides stercoralis</span> hyperinfection in a patient with rheumatoid arthritis after anti-TNF-alpha therapy" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "R. Krishnamurthy" 1 => "H.E. Dincer" 2 => "D. Whittemore" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/RHU.0b013e3180690933" "Revista" => array:6 [ "tituloSerie" => "J Clin Rheumatol" "fecha" => "2007" "volumen" => "13" "paginaInicial" => "150" "paginaFinal" => "152" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17551383" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0095" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "<span class="elsevierStyleItalic">Strongyloides stercolaris</span> in a patient with rheumatoid arthritis undergoing treatment with etanercept" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "E. Revuelta Evrard" 1 => "P.V. García Morales" 2 => "A. Gallego Flores" 3 => "A. Sánchez Trenado" 4 => "C. Rubio Caja" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S1699-258X(08)71805-9" "Revista" => array:6 [ "tituloSerie" => "Reumatol Clin" "fecha" => "2008" "volumen" => "4" "paginaInicial" => "77" "paginaFinal" => "79" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21794503" "web" => "Medline" ] ] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0100" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "<span class="elsevierStyleItalic">Strongyloides stercoralis</span> in a patient with ankylosing spondylitis: Case report" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "K. Yanık" 1 => "A. Karadağ" 2 => "H. Odabaşı" 3 => "N. Unal" 4 => "L. Altıntop" 5 => "M. Hökelek" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.5152/tpd.2013.31" "Revista" => array:6 [ "tituloSerie" => "Turkiye Parazitol Derg" "fecha" => "2013" "volumen" => "37" "paginaInicial" => "143" "paginaFinal" => "146" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23955914" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] "agradecimientos" => array:1 [ 0 => array:4 [ "identificador" => "xack280253" "titulo" => "Acknowledgments" "texto" => "<p id="par0040" class="elsevierStylePara elsevierViewall">We thank the Microbiology Department of Hospital Universitario La Paz for collaboration on this article.</p>" "vista" => "all" ] ] ] "idiomaDefecto" => "en" "url" => "/15782190/0000010800000004/v1_201704280927/S1578219017300471/v1_201704280927/en/main.assets" "Apartado" => array:4 [ "identificador" => "6157" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Case and Research Letters" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/15782190/0000010800000004/v1_201704280927/S1578219017300471/v1_201704280927/en/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219017300471?idApp=UINPBA000044" ]
| año/Mes | Html | Total | |
|---|---|---|---|
| 2024 Noviembre | 9 | 4 | 13 |
| 2024 Octubre | 70 | 34 | 104 |
| 2024 Septiembre | 81 | 23 | 104 |
| 2024 Agosto | 114 | 54 | 168 |
| 2024 Julio | 97 | 23 | 120 |
| 2024 Junio | 111 | 32 | 143 |
| 2024 Mayo | 60 | 40 | 100 |
| 2024 Abril | 106 | 20 | 126 |
| 2024 Marzo | 82 | 33 | 115 |
| 2024 Febrero | 60 | 28 | 88 |
| 2024 Enero | 56 | 33 | 89 |
| 2023 Diciembre | 60 | 23 | 83 |
| 2023 Noviembre | 63 | 30 | 93 |
| 2023 Octubre | 74 | 24 | 98 |
| 2023 Septiembre | 49 | 39 | 88 |
| 2023 Agosto | 60 | 12 | 72 |
| 2023 Julio | 74 | 40 | 114 |
| 2023 Junio | 86 | 30 | 116 |
| 2023 Mayo | 58 | 21 | 79 |
| 2023 Abril | 50 | 27 | 77 |
| 2023 Marzo | 69 | 20 | 89 |
| 2023 Febrero | 52 | 10 | 62 |
| 2023 Enero | 39 | 26 | 65 |
| 2022 Diciembre | 74 | 37 | 111 |
| 2022 Noviembre | 48 | 30 | 78 |
| 2022 Octubre | 28 | 16 | 44 |
| 2022 Septiembre | 23 | 35 | 58 |
| 2022 Agosto | 62 | 35 | 97 |
| 2022 Julio | 60 | 33 | 93 |
| 2022 Junio | 23 | 27 | 50 |
| 2022 Mayo | 62 | 38 | 100 |
| 2022 Abril | 97 | 26 | 123 |
| 2022 Marzo | 111 | 43 | 154 |
| 2022 Febrero | 105 | 34 | 139 |
| 2022 Enero | 80 | 31 | 111 |
| 2021 Diciembre | 55 | 40 | 95 |
| 2021 Noviembre | 74 | 44 | 118 |
| 2021 Octubre | 50 | 45 | 95 |
| 2021 Septiembre | 40 | 33 | 73 |
| 2021 Agosto | 33 | 32 | 65 |
| 2021 Julio | 31 | 26 | 57 |
| 2021 Junio | 31 | 26 | 57 |
| 2021 Mayo | 26 | 31 | 57 |
| 2021 Abril | 61 | 34 | 95 |
| 2021 Marzo | 60 | 20 | 80 |
| 2021 Febrero | 57 | 26 | 83 |
| 2021 Enero | 20 | 14 | 34 |
| 2020 Diciembre | 35 | 19 | 54 |
| 2020 Noviembre | 30 | 23 | 53 |
| 2020 Octubre | 27 | 20 | 47 |
| 2020 Septiembre | 35 | 12 | 47 |
| 2020 Agosto | 37 | 22 | 59 |
| 2020 Julio | 22 | 12 | 34 |
| 2020 Junio | 32 | 28 | 60 |
| 2020 Mayo | 21 | 11 | 32 |
| 2020 Abril | 23 | 14 | 37 |
| 2020 Marzo | 28 | 18 | 46 |
| 2020 Febrero | 4 | 0 | 4 |
| 2020 Enero | 4 | 0 | 4 |
| 2019 Diciembre | 4 | 0 | 4 |
| 2019 Noviembre | 3 | 0 | 3 |
| 2019 Septiembre | 7 | 0 | 7 |
| 2019 Agosto | 4 | 0 | 4 |
| 2019 Julio | 4 | 0 | 4 |
| 2019 Junio | 5 | 0 | 5 |
| 2019 Mayo | 6 | 1 | 7 |
| 2019 Abril | 15 | 3 | 18 |
| 2019 Marzo | 2 | 0 | 2 |
| 2019 Febrero | 4 | 0 | 4 |
| 2019 Enero | 2 | 0 | 2 |
| 2018 Diciembre | 10 | 0 | 10 |
| 2018 Noviembre | 3 | 0 | 3 |
| 2018 Octubre | 3 | 1 | 4 |
| 2018 Septiembre | 5 | 0 | 5 |
| 2018 Febrero | 57 | 4 | 61 |
| 2018 Enero | 51 | 3 | 54 |
| 2017 Diciembre | 100 | 8 | 108 |
| 2017 Noviembre | 31 | 6 | 37 |
| 2017 Octubre | 24 | 6 | 30 |
| 2017 Septiembre | 29 | 19 | 48 |
| 2017 Agosto | 29 | 29 | 58 |
| 2017 Julio | 25 | 19 | 44 |
| 2017 Junio | 45 | 9 | 54 |
| 2017 Mayo | 55 | 29 | 84 |
| 2017 Abril | 22 | 12 | 34 |
| 2017 Marzo | 1 | 5 | 6 |
Mostrar todo
